CatalystWireBeta

Arecor Therapeutics

AREC · AIM · Health Care · mcap £28m · 72.5p

Beta Briefing, track record and bull & bear case are not ready for Arecor Therapeutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 35 companies are already wired into a briefing: browse them.

John Lucius Arthur Cary 10 Aug · 1 notice
7.0% → 8.0%
share price at the notices 58.5p · now 72.5p 10 Aug 2026
Lucius Cary 11 Nov – 17 Nov · 2 notices
3.1% → 7.0%
share price at the notices 74.0p · now 72.5p 11 Nov 2025 17 Nov 2025
Calculus Capital Limited 8 Oct · 1 notice
6.4% → 5.3%
share price at the notices 72.5p · now 72.5p 8 Oct 2026

Directors

No open-market share purchases by directors in 12 months.

award Arecor Therapeutics plc announced the grant of 455,000 Long Term Incentive Plan options over new ordinary shares at an exercise price of £0.01 each. These options were awarded to key personnel, including the CEO, CFO, CS 21 May 2026

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note